| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Revenue | $266.8M | +5.6% |
| Cost of Revenue | $86.3M | +35.5% |
| Gross Profit | $180.5M | -4.5% |
| R&D Expense | $210.7M | +39.9% |
| SG&A Expense | $77.2M | +26.4% |
| Operating Income | -$290.5M | -48.1% |
| Pre-tax Income | -$268.2M | -40.2% |
| Income Tax | $675K | -14.4% |
| Net Income | -$268.8M |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $284.8M | -16.1% |
| Short-term Investments | $446.2M | -28.1% |
| Accounts Receivable | $134.6M | +67.7% |
| Current Assets | $888.9M | -16.2% |
| Total Assets | $1.10B | -5.8% |
| Current Liabilities | $136.0M | -9.4% |
| Total Liabilities | $173.4M | -4.4% |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$115.7M | -33.8% |
| Capital Expenditures | $70.5M | +1760.1% |
| Investing Cash Flow | $59.9M | -81.1% |
| Financing Cash Flow | $621K | -89.1% |
| Free Cash Flow | -$186.2M | -106.3% |
| -40.0% |
| Stockholders' Equity |
| $929.7M |
| -6.0% |